The Effect of Catheter Ablation on Sexual Dysfunction

The exposure in this prospective observational cohort study is catheter ablation for atrial fibrillation (AF) with the control group being medical therapy for AF. Participants will receive catheter ablation regardless of their involvement in this study, and not because of enrolment into the study. Participants must have been independently referred for catheter ablation for standard of care reasons prior to enrollment. Patients will be required to complete a number of questionnaires with a total time commitment of approximately 30 minutes at study enrollment, and at 6 months follow-up (study conclusion). The questionnaires will specifically include the Sexual quality of life (male and female) survey, the international index of erectile dysfunction, the premature ejaculation diagnostic tool, the sexual health inventory for men, and the female sexual function index. Furthermore, the Canadian cardiovascular society AF score, New York Heart Association Dyspnea scale, and the DASS-21 will also be administered. Baseline clinical information and procedural information will also be included in the assessment. These will be entered on initial study enrollment and from the medical records.